After rejection, FDA approves Telix’s Pixclara, the first FET-PET imaging drug for brain cancer Read more →
GSK doubles down on Chimagen with $750M multiple myeloma wager Read more →
Novo walks away from $285M pact to develop monthly GLP-1 obesity drug with Ascendis Read more →
